{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:26:00Z","timestamp":1778775960973,"version":"3.51.4"},"reference-count":51,"publisher":"Radcliffe Medical Media Ltd","license":[{"start":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T00:00:00Z","timestamp":1635811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/legalcode"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Mechanical circulatory support devices provide hemodynamic support to patients who present with cardiogenic shock. These devices work using different mechanisms to provide univentricular or biventricular support. There is a growing body of evidence supporting use of these devices as a goal for cardiac recovery or as a bridge to definitive therapy, but definitive, well-powered studies are still needed. Mechanical circulatory support devices are increasingly used using shock team and protocols, which can help clinicians in decision making, balancing operator and institutional experience and expertise. The aim of this article is to review commercially available mechanical circulatory support devices, their profiles and mechanisms of action, and the evidence available regarding their use.<\/jats:p>","DOI":"10.15420\/usc.2021.15","type":"journal-article","created":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T10:31:21Z","timestamp":1635849081000},"source":"Crossref","is-referenced-by-count":14,"title":["Current Landscape of Temporary Percutaneous Mechanical Circulatory Support Technology"],"prefix":"10.15420","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0507-9312","authenticated-orcid":false,"given":"Rani","family":"Upadhyay","sequence":"first","affiliation":[{"name":"Section of Interventional Cardiology, Stanford Health Care, Oakland, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0940-061X","authenticated-orcid":false,"given":"Hussayn","family":"Alrayes","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Henry Ford Hospital, Detroit, MI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5921-3308","authenticated-orcid":false,"given":"Scott","family":"Arno","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Henry Ford Hospital, Detroit, MI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1860-5978","authenticated-orcid":false,"given":"Milan","family":"Kaushik","sequence":"additional","affiliation":[{"name":"Wayne State University, Detroit, MI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3486-6753","authenticated-orcid":false,"given":"Mir B","family":"Basir","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Henry Ford Hospital, Detroit, MI"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6096","published-online":{"date-parts":[[2021,11,2]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Basir MB, Schreiber TL, Grines CL, et al. Effect of early initiation of mechanical circulatory support on survival in cardiogenic shock. Am J Cardiol 2017;119:845\u201351. https:\/\/doi.org\/10.1016\/j.amjcard.2016.11.037; PMID:\u00a028040188.","DOI":"10.1016\/j.amjcard.2016.11.037"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Shahin J, DeVarennes B, Tse CW, et al. The relationship between inotrope exposure, six-hour postoperative physiological variables, hospital mortality and renal dysfunction in patients undergoing cardiac surgery. Crit Care 2011;15:R162. https:\/\/doi.org\/10.1186\/cc10302; PMID:\u00a021736726.","DOI":"10.1186\/cc10302"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Tariq S, Aronow WS. Use of inotropic agents in treatment of systolic heart failure. Int J Mol Sci 2015;16:29060\u20138. https:\/\/doi.org\/10.3390\/ijms161226147; PMID:\u00a026690127.","DOI":"10.3390\/ijms161226147"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Saku K, Kakino T, Arimura T, et al. Left ventricular mechanical unloading by total support of impella in myocardial infarction reduces infarct size, preserves left ventricular function, and prevents subsequent heart failure in dogs. Circ Heart Fail 2018;11:e004397. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.117.004397; PMID:\u00a029739745.","DOI":"10.1161\/circheartfailure.117.004397"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Thiele H, Zeymer U, Neumann FJ, et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet 2013;382:1638\u201345. https:\/\/doi.org\/10.1016\/S0140-6736(13)61783-3; PMID:\u00a024011548.","DOI":"10.1016\/S0140-6736(13)61783-3"},{"key":"ref5","unstructured":"Ibanez B, James S, Agewall S, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2018;39:119\u201377. https:\/\/doi.org\/10.1093\/eurheartj\/ehx393; PMID:\u00a028886621."},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Patel H, Shivaraju A, Fonarow GC et al. Temporal trends in the use of intraaortic balloon pump associated with percutaneous coronary intervention in the United States, 1998-2008. Am Heart J 2014;168:363\u201373. https:\/\/doi.org\/10.1016\/j.ahj.2014.02.015; PMID:\u00a025173549.","DOI":"10.1016\/j.ahj.2014.02.015"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Lauten A, Engstr\u00f6m AE, Jung C, et al. Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry. Circ Heart Fail 2013;6:23\u201330. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.112.967224; PMID:\u00a023212552.","DOI":"10.1161\/CIRCHEARTFAILURE.112.967224"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"O\u2019Neill WW, Schreiber T, Wohns DH, et al. The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella Registry. J Interv Cardiol 2014;27:1\u201311. https:\/\/doi.org\/10.1111\/joic.12080; PMID:\u00a024329756.","DOI":"10.1111\/joic.12080"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Loehn T, O\u2019Neill WW, Lange B, et al. Long term survival after early unloading with Impella CP\u00ae\u00a0in acute myocardial infarction complicated by cardiogenic shock. Eur Heart J Acute Cardiovasc Care 2020;9:149\u201357. https:\/\/doi.org\/10.1177\/2048872618815063; PMID:\u00a030456984.","DOI":"10.1177\/2048872618815063"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Seyfarth M, Sibbing D, Bauer I, et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol 2008;52:1584\u20138. https:\/\/doi.org\/10.1016\/j.jacc.2008.05.065; PMID:\u00a019007597.","DOI":"10.1016\/j.jacc.2008.05.065"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Ouweneel DM, Eriksen E, Sjauw KD, et al. Percutaneous mechanical circulatory support versus intra-aortic balloon pump\u00a0in cardiogenic shock after acute\u00a0myocardial infarction. J Am Coll Cardiol 2017;69:278\u201387. https:\/\/doi.org\/10.1016\/j.jacc.2016.10.022; PMID:\u00a027810347.","DOI":"10.1016\/j.jacc.2016.10.026"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Basir MB, Pinto DS, Ziaeian B, et al. Mechanical circulatory support in acute myocardial infarction and cardiogenic shock: challenges and importance of randomized control trials. Catheter Cardiovasc Interv 2021. https:\/\/doi.org\/10.1002\/ccd.29593; PMID:\u00a033682260; epub ahead of press.","DOI":"10.1002\/ccd.29593"},{"key":"ref13","unstructured":"Schrage B, Ibrahim K, Loehn T, et al. Impella support for acute myocardial infarction complicated by cardiogenic shock. Circulation 2019;139:1249\u201358. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.036614; PMID:\u00a030586755."},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Helgestad OKL, Josiassen J, Hassager C, et al. Contemporary trends in use of mechanical circulatory support in patients with acute MI and cardiogenic shock. Open Heart 2020;7:e001214. https:\/\/doi.org\/10.1136\/openhrt-2019-001214; PMID:\u00a032201591.","DOI":"10.1136\/openhrt-2019-001214"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Basir MB, Schreiber T, Dixon S, et al. Feasibility of early mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock: The Detroit cardiogenic shock initiative. Catheter Cardiovasc Interv 2018;91:454\u201361. https:\/\/doi.org\/10.1002\/ccd.27427; PMID:\u00a029266676.","DOI":"10.1002\/ccd.27427"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Basir MB, Kapur NK, Patel K, et al. Improved outcomes associated with the use of shock protocols: updates from the National Cardiogenic Shock Initiative. Catheter Cardiovasc Interv 2019;93:1173\u201383. https:\/\/doi.org\/10.1002\/ccd.28307; PMID:\u00a031025538.","DOI":"10.1002\/ccd.28307"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Thiele H, Sick P, Boudriot E, et al. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 2005;26:1276\u201383. https:\/\/doi.org\/10.1093\/eurheartj\/ehi161; PMID:\u00a015734771.","DOI":"10.1093\/eurheartj\/ehi161"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Burkhoff D, Cohen H, Brunckhorst C, et al. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J 2006;152:469.e1\u20138. https:\/\/doi.org\/10.1016\/j.ahj.2006.05.031; PMID:\u00a016923414.","DOI":"10.1016\/j.ahj.2006.05.031"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Negi SI, Malahfji M, Sokolovic M et al. TCT-199. A comparative analysis of use of extracorporeal membrane oxygenation and peripheral ventricular assist device tandemheart in acute myocardial infarction. J Am Coll Cardiol 2015;66(15 Suppl):B75\u20136. https:\/\/doi.org\/10.1016\/j.jacc.2015.08.213.","DOI":"10.1016\/j.jacc.2015.08.213"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Kar B, Gregoric ID, Basra SS, et al. The percutaneous ventricular assist device in severe refractory cardiogenic shock. J Am Coll Cardiol 2011;57:688\u201396. https:\/\/doi.org\/10.1016\/j.jacc.2010.08.613; PMID:\u00a020950980.","DOI":"10.1016\/j.jacc.2010.08.613"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Smith L, Peters A, Mazimba S, et al. Outcomes of patients with cardiogenic shock treated with TandemHeart\u00ae percutaneous ventricular assist device: Importance of support indication and definitive therapies as determinants of prognosis. Catheter Cardiovasc Interv 2018;92:1173\u201381. https:\/\/doi.org\/10.1002\/ccd.27650; PMID:\u00a029745477.","DOI":"10.1002\/ccd.27650"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Garan AR, Takeda K, Salna M, et al. Prospective comparison of a percutaneous ventricular assist device and venoarterial extracorporeal membrane oxygenation for patients with cardiogenic shock following acute myocardial infarction. J Am Heart Assoc 2019;8:e012171. https:\/\/doi.org\/10.1161\/JAHA.119.012171; PMID:\u00a031041870.","DOI":"10.1161\/jaha.119.012171"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Vallabhajosyula S, Bell MR, Sandhu GS, et al. Complications in patients with acute myocardial infarction supported with extracorporeal membrane oxygenation. J Clin Med 2020;9:839. https:\/\/doi.org\/10.3390\/jcm9030839; PMID:\u00a032204507.","DOI":"10.3390\/jcm9030839"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Lemor A, Hosseini Dehkordi SH, et al. Impella versus extracorporeal membrane oxygenation for acute myocardial infarction cardiogenic shock. Cardiovasc Revasc Med 2020;21:1465\u201371. https:\/\/doi.org\/10.1016\/j.carrev.2020.05.042; PMID:\u00a032605901.","DOI":"10.1016\/j.carrev.2020.05.042"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Sheu JJ, Tsai TH, Lee FY, et al. Early extracorporeal membrane oxygenator-assisted primary percutaneous coronary intervention improved 30-day clinical outcomes in patients with ST-segment elevation myocardial infarction complicated with profound cardiogenic shock. Crit Care Med 2010;38:1810\u20137. https:\/\/doi.org\/10.1097.CCM.0b013e3181e8acf7; PMID:\u00a020543669.","DOI":"10.1097\/ccm.0b013e3181e8acf7"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Esper SA, Bermudez C, Dueweke EJ, et al. Extracorporeal membrane oxygenation support in acute coronary syndromes complicated by cardiogenic shock. Catheter Cardiovasc Interv 2015;86 Suppl 1:S45\u201350.\u00a0https:\/\/doi.org\/10.1002\/ccd.25871 PMID:\u00a025639707.","DOI":"10.1002\/ccd.25871"},{"key":"ref27","unstructured":"Negi SI, Sokolovic M, Koifman E, et al. Contemporary use of veno-arterial extracorporeal membrane oxygenation for refractory cardiogenic shock in acute coronary syndrome. J Invasive Cardiol 2016;28:52\u20137; PMID:\u00a026689415."},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Mizuno M, Sato N, Kajimoto K, et al. Intra-aortic balloon counterpulsation for acute decompensated heart failure. Int J Cardiol 2014;176:1444\u20136. https:\/\/doi.org\/10.1016\/j.ijcard.2014.08.154; PMID:\u00a025223815.","DOI":"10.1016\/j.ijcard.2014.08.154"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Malick W, Fried JA, Masoumi A, et al. Comparison of the hemodynamic response to intra-aortic balloon counterpulsation in patients with cardiogenic shock resulting from acute myocardial infarction versus acute decompensated heart failure. Am J Cardiol 2019;124:1947\u201353. https:\/\/doi.org\/10.1016\/j.amjcard.2019.09.016; PMID:\u00a031648782.","DOI":"10.1016\/j.amjcard.2019.09.016"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Fried JA, Nair A, Takeda K, et al. Clinical and hemodynamic effects of intra-aortic balloon pump therapy in chronic heart failure patients with cardiogenic shock. J Heart Lung Transplant 2018;37:1313\u201321. https:\/\/doi.org\/10.1016\/j.healun.2018.03.011; PMID:\u00a029678608.","DOI":"10.1016\/j.healun.2018.03.011"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Sintek MA, Gdowski M, Lindman BR, et al. Intra-aortic balloon counterpulsation in patients with chronic heart failure and cardiogenic shock: clinical response and predictors of stabilization. J Card Fail 2015;21:868\u201376. https:\/\/doi.org\/10.1016\/j.cardfail.2015.06.383; PMID:\u00a026164215.","DOI":"10.1016\/j.cardfail.2015.06.383"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Hsu S, Kambhampati S, Sciortino CM, et al. Predictors of intra-aortic balloon pump hemodynamic failure in non-acute myocardial infarction cardiogenic shock. Am Heart J 2018;199:181\u201391. https:\/\/doi.org\/10.1016\/j.ahj.2017.11.016; PMID:\u00a029754660.","DOI":"10.1016\/j.ahj.2017.11.016"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Malick W, Fried JA, Masoumi A, et al. Comparison of the hemodynamic response to intra-aortic balloon counterpulsation in patients with cardiogenic shock resulting from acute myocardial infarction versus acute decompensated heart failure. Am J Cardiol 2019;124:1947\u201353. https:\/\/doi.org\/10.1016\/j.amjcard.2019.09.016; PMID:\u00a031648782.","DOI":"10.1016\/j.amjcard.2019.09.016"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Morici N, Marini C, Sacco A, et al. Early intra-aortic balloon pump in acute decompensated heart failure complicated by cardiogenic shock: rationale and design of the randomized Altshock-2 trial. Am Heart J 2021;233:39\u201347. https:\/\/doi.org\/10.1016.j.ahj.2020.11.017; PMID:\u00a033338464.","DOI":"10.1016\/j.ahj.2020.11.017"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Nersesian G, Hennig F, M\u00fcller M, et al. Temporary mechanical circulatory support for refractory heart failure: the German Heart Center Berlin experience. Ann Cardiothorac Surg 201 ;8:76\u201383. https:\/\/doi.org\/10.21037\/acs.2018.12.01; PMID:\u00a030854315.","DOI":"10.21037\/acs.2018.12.01"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Elkayam U, Sch\u00e4fer A, Chieffo A, et al. Use of Impella heart pump for management of women with peripartum cardiogenic shock. Clin Cardiol 2019;42:974\u201381. https:\/\/doi.org\/10.1002\/clc.23249; PMID:\u00a031436333.","DOI":"10.1002\/clc.23249"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Annamalai SK, Esposito ML, Jorde L, et al. Impella Microaxial flow catheter is safe and effective for treatment of myocarditis complicated by cardiogenic shock: an analysis from the global cVAD registry. J Card Fail 2018;24:706\u201310. https:\/\/doi.org\/10.1016\/j.cardfail.2018.09.007; PMID:\u00a030244180.","DOI":"10.1016\/j.cardfail.2018.09.007"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Watanabe S, Fish K, Kovacic JC, et al. Left ventricular unloading using an Impella CP improves coronary flow and infarct zone perfusion in ischemic heart failure. J Am Heart Assoc 2018;7:e006462. https:\/\/doi.org\/10.1161\/JAHA.117.006462: PMID:\u00a029514806.","DOI":"10.1161\/JAHA.117.006462"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Monteagudo Vela M, Simon A, et al. Clinical indications of IMPELLA short-term mechanical circulatory support in a tertiary centre. Cardiovasc Revasc Med 2020;21:629\u201337. https:\/\/doi.org\/10.1016\/j.carrev.2019.12.010; PMID:\u00a031859100.","DOI":"10.1016\/j.carrev.2019.12.010"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"van Diepen S, Katz JN, Albert NM, et al. Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association. Circulation 2017;136:e232\u201368. https:\/\/doi.org\/10.1161\/CIR.0000000000000525; PMID:\u00a028923988.","DOI":"10.1161\/cir.0000000000000525"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Paden ML, Conrad SA, Rycus PT, et al. Extracorporeal life support organization registry report 2012. ASAIO J 2013;59:202\u201310. https:\/\/doi.org\/10.1097\/MAT.0b013e3182904a52; PMID:\u00a023644605.","DOI":"10.1097\/mat.0b013e3182904a52"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Br\u00e9chot N, Hajage D, Kimmoun A, et al. Venoarterial extracorporeal membrane oxygenation to rescue sepsis-induced cardiogenic shock: a retrospective, multicentre, international cohort study. Lancet 2020;396:545\u201352. https:\/\/doi.org\/10.1016\/S0140-6736(20)30733-9; PMID:\u00a032828186.","DOI":"10.1016\/s0140-6736(20)30733-9"},{"key":"ref43","unstructured":"Extracorporeal Life Support Organization. ECLS registry report: international summary \u2013 April 2021. https:\/\/www.elso.org\/registry\/statistics\/internationalsummary.aspx (accessed August 31, 2021)."},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Chakaramakkil MJ, Sivathasan C. ECMO and short-term support for cardiogenic shock in heart failure. Curr Cardiol Rep 2018;20:87. https:\/\/doi.org\/10.1007\/s11886-018-1041-4; PMID:\u00a030116917.","DOI":"10.1007\/s11886-018-1041-4"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Jacobs AK, Leopold JA, Bates E, et al. Cardiogenic shock caused by right ventricular infarction: a report from the SHOCK registry. J Am Coll Cardiol 2003;41:1273\u20139. https:\/\/doi.org\/10.1016\/s0735-1097(03)00120-7; PMID:\u00a012706920.","DOI":"10.1016\/S0735-1097(03)00120-7"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Lala A, Guo Y, Xu J, et al. Right ventricular dysfunction in acute myocardial infarction complicated by cardiogenic shock: a hemodynamic analysis of the should we emergently revascularize occluded coronaries for cardiogenic shock (SHOCK) trial and registry. J Card Fail 2018;24:148\u201356. https:\/\/doi.org\/10.1016\/j.cardfail.2017.10.009; PMID:\u00a029032225.","DOI":"10.1016\/j.cardfail.2017.10.009"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Gramegna M, Beneduce A, Bertoldi LF, et al. Impella RP support in refractory right ventricular failure complicating acute myocardial infarction with unsuccessful right coronary artery revascularization. Int J Cardiol 2020;302:135\u20137. https:\/\/doi.org\/10.1016\/j.ijcard.2019.12.024; PMID:\u00a031866154.","DOI":"10.1016\/j.ijcard.2019.12.024"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"Cheung AW, White CW, Davis MK, Freed DH. Short-term mechanical circulatory support for recovery from acute right ventricular failure: clinical outcomes. J Heart Lung Transplant. 2014;33:794\u00ad\u20139. https:\/\/doi.org\/10.1016\/j.healun.2014.02.028; PMID:\u00a024726682.","DOI":"10.1016\/j.healun.2014.02.028"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"Anderson M, Morris DL, Tang D, et al. Outcomes of patients with right ventricular failure requiring short-term hemodynamic support with the Impella RP device. J Heart Lung Transplant. 2018;37:1448\u201358. https:\/\/doi.org\/10.1016\/j.healun.2018.08.001; PMID:\u00a030241890.","DOI":"10.1016\/j.healun.2018.08.001"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Kapur NK, Paruchuri V, Jagannathan A, et al. Mechanical circulatory support for right ventricular failure. JACC Heart Fail 2013;1:127\u201334. https:\/\/doi.org\/10.1016\/j.jchf.2013.01.007; PMID:\u00a024621838.","DOI":"10.1016\/j.jchf.2013.01.007"}],"container-title":["US Cardiology Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.uscjournal.com\/articleindex\/usc.2021.15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T10:31:51Z","timestamp":1635849111000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.uscjournal.com\/articleindex\/usc.2021.15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,2]]},"references-count":51,"URL":"https:\/\/doi.org\/10.15420\/usc.2021.15","relation":{},"ISSN":["1758-390X","1758-3896"],"issn-type":[{"value":"1758-390X","type":"electronic"},{"value":"1758-3896","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,2]]},"article-number":"e21"}}